3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
17
Phase 1
13
Phase 1/2
3
Phase EARLY_PHASE1
1
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
61
Cyclophosphamide
57
pembrolizumab
39
fludarabine
38
Radiotherapy
30
Nivolumab
30
Biopsy
27
Metformin
23
Fluorodeoxyglucose F18
22
Bevacizumab
22
Specimen Handling
21
Temozolomide
18
Cisplatin
18
Radiosurgery
17
Carboplatin
16
Fluorouracil
15
Paclitaxel
14
Dexamethasone
14
Radiation
13
Gemcitabine
13
Etoposide
13
Rituximab
12
Positron Emission Tomography Computed Tomography
12
Letrozole
12
Irinotecan
12
gallium 68 PSMA-11
11
durvalumab
11
atezolizumab
11
X-Rays
11
Surgical Procedures, Operative
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Interventional
×
reolysin
×
Clear all
NCT04102618
2022-08-15
AWARE-1
Oncolytics Biotech
Phase EARLY_PHASE1
Terminated
26 enrolled